A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation.
Bettina Langhans(University Hospital Bonn), Ulrich Spengler(University of Bonn), El Bakri M, Tilman Sauerbruch(University Hospital Bonn), G. Jung(University of Bonn), Hans Georg Ihlenfeldt(University of Bonn), Susann Schweitzer, G. Giers(University of Bonn), Martin Lechmann(Roche (Switzerland))
PubMed
March 27, 2000
Cited by 13
Related Papers
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
|Hepatology|2008|345
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
|American Journal Of Pathology|2005|171
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
|Proceedings of the National Academy of Sciences|2003|170